Related Experiment Video
Updated: Aug 15, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Activity and nature of p21(WAF1) complexes during the cell cycle
1Department of Molecular and Cellular Biology, Harvard University, 16 Divinity Avenue, Cambridge, MA 02138, USA.
Abstract:
Elevated levels of the p21(WAF1) (p21) cyclin-dependent kinase inhibitor induce growth arrest. We have characterized a panel of monoclonal antibodies against human p21 in an effort to understand the dynamic regulatory interactions between this and other cellular proteins during the cell cycle. The use of these reagents has allowed us to address several important, yet unresolved, issues concerning the biological activity of p21, including the potential kinase activity of complexes that associate with this cyclin-dependent kinase inhibitor. We have found that the kinase activity of cyclin A/Cdk2 associated with p21 is significantly lower than that of cyclin A/Cdk2 free of p21, suggesting that p21 abolishes its activity in vivo, and the use of multiple antibodies has enabled us to begin the study of the molecular architecture of p21 complexes in vivo. In addition, we found that human fibroblasts released from a quiescent state display abundant amounts of p21 devoid of associated proteins ("free" p21), the levels of which decrease as cells approach S phase. Cyclin A levels increase as the amount of monomeric p21 decreases, resulting in an excess of cyclin A/Cdk2 complexes that are not bound to, or inactivated by, p21. Our data strengthen the notion that the G1-to-S phase transition in human fibroblasts occurs when the concentration of cyclin A/Cdk2 surpasses that of p21.
Insights
Monoclonal antibodies reveal that p21 (WAF1) cyclin-dependent kinase inhibitor inactivates cyclin A/Cdk2 kinase activity. This inactivation is crucial for regulating the G1-to-S phase transition in human fibroblasts.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Elevated p21(WAF1) (p21) levels induce cell growth arrest.
- Understanding p21's regulatory interactions is key to cell cycle control.
Purpose of the Study:
- Characterize monoclonal antibodies against human p21.
- Investigate p21's role in regulating cyclin A/Cdk2 kinase activity.
- Elucidate the molecular architecture of p21 complexes.
Main Methods:
- Monoclonal antibody generation and characterization.
- Analysis of kinase activity in p21-associated complexes.
- Western blot analysis of protein levels during cell cycle progression.
Main Results:
- p21 binding significantly reduces cyclin A/Cdk2 kinase activity, suggesting in vivo inactivation.
- Multiple antibodies enabled initial studies of p21 complex molecular architecture.
- Quiescent fibroblasts show high levels of 'free' p21, which decreases as cells enter S phase.
- Cyclin A levels rise as free p21 decreases, leading to excess active cyclin A/Cdk2.
Conclusions:
- p21 acts as a critical inhibitor of cyclin A/Cdk2 activity.
- The G1-to-S phase transition is regulated by the relative concentrations of cyclin A/Cdk2 and p21.
More Related Videos
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
12:26Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Related Concept Videos
Positive Regulator Molecules
Negative Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Anaphase Promoting Complex
Anaphase Promoting Complex